Literature DB >> 2089879

Human malignant gliomas secrete a factor that increases brain capillary permeability: role in peritumoural brain oedema.

T Ohnishi1, T Hayakawa, W R Shapiro.   

Abstract

The effect of conditioned media obtained from two human malignant gliomas and normal human glia on rat brain capillary permeability was investigated by measuring the entry of 14C-aminoisobutyric acid by a quantitative autoradiographic method. Conditioned media were concentrated 50-fold to create SUP-C. The SUP-C contained proteins with a molecular weight greater than 10 kD. The SUP-C from glioma cells markedly increased brain capillary permeability, whereas that from normal glial cells did not. The activity of capillary permeability factor in the SUP-C was significantly inhibited by pretreatment of animals with dexamethasone or BW755C (lipoxygenase inhibitor), but not with indomethacin. On the other hand, coincubation of glioma cells with dexamethasone produced SUP-C whose capillary permeability activity was about one and a half times greater than that without dexamethasone. These results indicate that human malignant glioma cells secrete a protein factor that increases brain capillary permeability. Glucocorticoids inhibit the effect of the factor by directly acting on capillary endothelial cells, possibly through the inhibition of phospholipase A2 activity, resulting in a decrease of lipoxygenase rather than cyclo-oxygenase products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089879     DOI: 10.1007/978-3-7091-9115-6_46

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  2 in total

1.  Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging.

Authors:  Sosuke Minamikawa; Kinuko Kono; Keiko Nakayama; Hiroyuki Yokote; Takahiko Tashiro; Akimasa Nishio; Mitsuhiro Hara; Yuichi Inoue
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

2.  Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging.

Authors:  C Andersen; J C Haselgrove; S Doenstrup; J Astrup; C Gyldensted
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.